An experienced investor shares insights on finding hidden gems in overlooked areas of the market, focusing on spinoff companies like Inhibrx Biosciences. With innovative biotech treatments targeting cancer and rare diseases, Inhibrx's unique approach and promising pipeline offer significant potential for investors seeking high-growth opportunities.